Brooks Laboratories Sells 16.33% Stake in Brooks Steriscience Limited for ₹106 Crore
Brooks Laboratories Limited has completed a partial sale of equity shares held in Brooks Steriscience Limited, monetizing part of its investment in the company. The transaction was approved by the Board of Directors on June 19, 2026.The Company sold 51,220 Equity Shares held in Brooks Steriscience Limited to Steriscience Specialties Private Limited. The sale was executed for a cash consideration of ₹20,760 per share, amounting to an aggregate value of ₹106,33,27,200.
The transaction marks a partial monetization of the Company's investment and does not constitute complete divestment. Following the disposal, Brooks Laboratories Limited will continue to hold 1,02,440 Equity Shares in Brooks Steriscience Limited, which represents 32.67% of the paid up share capital of Brooks Steriscience Limited.
The proceeds generated from this transaction are earmarked for deployment towards the Company's growth strategy. This includes expanding operations, enhancing capacity, and funding various business opportunities and general corporate purposes.
Key details regarding the disposal of equity shares in Brooks Steriscience Limited are provided below:
| Particulars | Details |
|---|---|
| Entity whose shares were transferred | Brooks Steriscience Limited |
| Shares disposed of | 51,220 Equity Shares (representing 16.33%) |
| Cash consideration per share | ₹20,760 |
| Aggregate Consideration | ₹106,33,27,200 |
| Shareholding Before Disposal | 49.00% |
| Shareholding After Disposal | 32.67% |
The transaction was approved by the Board of Directors during a meeting held on June 19, 2026. The board meeting commenced at 16:00 hours and concluded at 19:30 hours.
BROOKS Stock Price Movement
Brooks Laboratories Limited’s equity shed value on Friday, finishing at ₹66.68 as it saw a notable decline following market activity. The stock traded through 12,640 shares during the session, settling below its previous closing price of ₹68.00.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.